|
|
|
||||||||||
Pharmacy Services Manager (Mental Health), Pharmacy Department, Kent and Canterbury Hospital, Ethelbert Rd., Canterbury, Kent CT1 3NG, England, FAX 44 1227 864094, ian.maidment{at}ekht.nhs.uk
Reprints: Ian D Maidment BPharm MRPharmS
OBJECTIVE: To review the literature regarding the efficacy of stimulants to treat attention-deficit-hyperactivity disorder (ADHD) in adults.
DATA SOURCES: The relevant pharmaceutical manufacturers were contacted, and searches of MEDLINE (1966December 2002) and the reference sections of each article obtained were performed using the key search terms: adult ADHD, stimulants, methylphenidate, amphetamines, and pemoline.
STUDY SELECTION AND DATA EXTRACTION: All English-language original studies identified from the data sources were evaluated and all information deemed relevant was included in the review.
DATA SYNTHESIS: Studies involving methylphenidate, amphetamines, and pemoline were identified. There was evidence for the efficacy of amphetamines from 5 studies (4 controlled, 1 open). Methylphenidate data from 6 controlled trials were conflicting. Three studies indicated efficacy; 2 studies failed to show efficacy, possibly due to methodologic reasons; and the results from 1 study were conflicting. The limited data from 1 controlled and 1 open study indicated that pemoline may be less effective than methylphenidate and amphetamines.
CONCLUSIONS: While the current limited data indicate that stimulants may be effective in adult ADHD, more data are required to confirm long-term efficacy.
Key Words: adult ADHD, amphetamines, methylphenidate, pemoline, stimulants
Published Online, October 29, 2003. www.theannals.com, DOI 10.1345/aph.1D028
THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE
UNIVERSAL PROGRAM NUMBER: 407-000-03-042-H01
This article has been cited by other articles:
![]() |
M Koesters, T Becker, R Kilian, J. Fegert, and S Weinmann Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder J Psychopharmacol, September 1, 2009; 23(7): 733 - 744. [Abstract] [PDF] |
||||
![]() |
D. J. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, K. A. Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology J Psychopharmacol, January 1, 2007; 21(1): 10 - 41. [Abstract] [PDF] |
||||